Literature DB >> 24020737

Radioimmunotherapy of Cryptococcus neoformans spares bystander mammalian cells.

Ruth A Bryan1, Zewei Jiang, Alfred Morgenstern, Frank Bruchertseifer, Arturo Casadevall, Ekaterina Dadachova.   

Abstract

AIM: Previously, we showed that radioimmunotherapy (RIT) for cryptococcal infections using radioactively labeled antibodies recognizing the cryptococcal capsule reduced fungal burden and prolonged survival of mice infected with Cryptococcus neoformans. Here, we investigate the effects of RIT on bystander mammalian cells. MATERIALS &
METHODS: Heat-killed C. neoformans bound to anticapsular antibodies, unlabeled or labeled with the β-emitter rhenium-188 (16.9-h half-life) or the α-emitter bismuth-213 (46-min half-life), was incubated with macrophage-like J774.16 cells or epithelial-like Chinese hamster ovary cells. Lactate dehydrogenase activity, crystal violet uptake, reduction of tetrazolium dye (2,3)-bis-(2-methoxy-4-nitro-5-sulfenyl)-(2H)-terazolium-5-carboxanilide and nitric oxide production were measured.
RESULTS: The J774.16 and Chinese hamster ovary cells maintained membrane integrity, viability and metabolic activity following exposure to radiolabeled C. neoformans.
CONCLUSION: RIT of C. neoformans is a selective therapy with minimal effects on host cells and these results are consistent with observations that RIT-treated mice with cryptococcal infection lacked RIT-related pathological changes in lungs and brain tissues.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24020737      PMCID: PMC3932562          DOI: 10.2217/fmb.13.79

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  17 in total

1.  Antibody-guided alpha radiation effectively damages fungal biofilms.

Authors:  L R Martinez; R A Bryan; C Apostolidis; A Morgenstern; A Casadevall; E Dadachova
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

2.  Radioimmunotherapy is effective against high-inoculum Cryptococcus neoformans infection in mice and does not select for radiation-resistant cryptococcal cells.

Authors:  Ruth A Bryan; Zewei Jiang; Xianchun Huang; Alfred Morgenstern; Frank Bruchertseifer; Rani Sellers; Arturo Casadevall; Ekaterina Dadachova
Journal:  Antimicrob Agents Chemother       Date:  2009-01-12       Impact factor: 5.191

3.  Radiofungicidal effects of external gamma radiation and antibody-targeted beta and alpha radiation on Cryptococcus neoformans.

Authors:  Ruth A Bryan; Xianchun Huang; Alfred Morgenstern; Frank Bruchertseifer; Arturo Casadevall; Ekaterina Dadachova
Journal:  Antimicrob Agents Chemother       Date:  2008-03-31       Impact factor: 5.191

4.  Antibody efficacy in murine pulmonary Cryptococcus neoformans infection: a role for nitric oxide.

Authors:  Johanna Rivera; Jean Mukherjee; Louis M Weiss; Arturo Casadevall
Journal:  J Immunol       Date:  2002-04-01       Impact factor: 5.422

Review 5.  Radioimmunotherapy of infectious diseases.

Authors:  Ekaterina Dadachova; Arturo Casadevall
Journal:  Semin Nucl Med       Date:  2009-03       Impact factor: 4.446

Review 6.  Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS.

Authors:  Benjamin J Park; Kathleen A Wannemuehler; Barbara J Marston; Nelesh Govender; Peter G Pappas; Tom M Chiller
Journal:  AIDS       Date:  2009-02-20       Impact factor: 4.177

7.  Susceptibility of the human pathogenic fungi Cryptococcus neoformans and Histoplasma capsulatum to gamma-radiation versus radioimmunotherapy with alpha- and beta-emitting radioisotopes.

Authors:  Ekaterina Dadachova; Roger W Howell; Ruth A Bryan; Annie Frenkel; Joshua D Nosanchuk; Arturo Casadevall
Journal:  J Nucl Med       Date:  2004-02       Impact factor: 10.057

Review 8.  Fungal invasion of normally non-phagocytic host cells.

Authors:  Scott G Filler; Donald C Sheppard
Journal:  PLoS Pathog       Date:  2006-12       Impact factor: 6.823

9.  Physico-chemical evaluation of rationally designed melanins as novel nature-inspired radioprotectors.

Authors:  Andrew D Schweitzer; Robertha C Howell; Zewei Jiang; Ruth A Bryan; Gary Gerfen; Chin-Cheng Chen; Dennis Mah; Sean Cahill; Arturo Casadevall; Ekaterina Dadachova
Journal:  PLoS One       Date:  2009-09-30       Impact factor: 3.240

10.  Cell-to-cell spread and massive vacuole formation after Cryptococcus neoformans infection of murine macrophages.

Authors:  Mauricio Alvarez; Arturo Casadevall
Journal:  BMC Immunol       Date:  2007-08-16       Impact factor: 3.615

View more
  6 in total

1.  A Monoclonal Antibody to Cryptococcus neoformans Glucuronoxylomannan Manifests Hydrolytic Activity for Both Peptides and Polysaccharides.

Authors:  Anthony Bowen; Maggie P Wear; Radames J B Cordero; Stefan Oscarson; Arturo Casadevall
Journal:  J Biol Chem       Date:  2016-11-21       Impact factor: 5.157

2.  Effects of radiation type and delivery mode on a radioresistant eukaryote Cryptococcus neoformans.

Authors:  Igor Shuryak; Ruth A Bryan; Jack Broitman; Stephen A Marino; Alfred Morgenstern; Christos Apostolidis; Ekaterina Dadachova
Journal:  Nucl Med Biol       Date:  2015-03-11       Impact factor: 2.408

3.  Microbicidal power of alpha radiation in sterilizing germinating Bacillus anthracis spores.

Authors:  Johanna Rivera; Alfred Morgenstern; Frank Bruchertseifer; John F Kearney; Charles L Turnbough; Ekaterina Dadachova; Arturo Casadevall
Journal:  Antimicrob Agents Chemother       Date:  2013-12-30       Impact factor: 5.191

Review 4.  Immunomodulation as Therapy for Fungal Infection: Are We Closer?

Authors:  Qi Hui Sam; Wen Shan Yew; Chaminda J Seneviratne; Matthew Wook Chang; Louis Yi Ann Chai
Journal:  Front Microbiol       Date:  2018-07-25       Impact factor: 5.640

Review 5.  Present and Future Therapy of Cryptococcus Infections.

Authors:  Ahmad Mourad; John R Perfect
Journal:  J Fungi (Basel)       Date:  2018-07-03

6.  Radioimmunotherapy of methicillin-resistant Staphylococcus aureus in planktonic state and biofilms.

Authors:  B van Dijk; K J H Allen; M Helal; H C Vogely; M G E H Lam; J M H de Klerk; H Weinans; B C H van der Wal; E Dadachova
Journal:  PLoS One       Date:  2020-05-14       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.